North America Capnography Equipment Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Product Type, Technology, Application, and End User

The capnography equipment market in North America is expected to grow from US$ 201.81 million in 2022 to US$ 302.81 million by 2028; it is estimated to grow at a CAGR of 7.0% from 2022 to 2028.

Chronic respiratory diseases are prevalent noncommunicable diseases worldwide due to the commonness of noxious environmental, occupational, and behavioral inhalation. This spectrum of diseases includes chronic obstructive pulmonary disease (COPD), asthma, interstitial lung disease, pulmonary sarcoidosis, and pneumoconiosis (such as silicosis and asbestosis). As Per the Office of Disease Prevention and Health Promotion, ~14.8 million adults in the US were diagnosed with COPD in 2020. According to the estimates by the Centers for Disease Control and Prevention (CDC), ~24.8 million people in the US were suffering from asthma in 2018. Moreover, in 2017, the country recorded an estimated 1.6 million emergency department (ED) visits and 183,000 hospitalizations due to asthma. Capnography is a method of monitoring the concentration or partial pressure of carbon dioxide (CO2 ). The continuous measurement of human respiratory CO2 by using a capnograph provides valuable information about cardiopulmonary resuscitation, endotracheal tube placement, pulmonary embolism, and procedural sedation. The equipment is also used to obtain information on the effect of air pollution on cardiopulmonary characteristics and the effectiveness of a treatment for a patient with respiratory distress. Changes in the shape of the capnogram are used to diagnose respiratory disease conditions. Changes in end-tidal CO2 (EtCO2) - i.e., the maximum CO2 concentration at the end of each tidal breath - can be used to assess disease severity and response to treatment. Therefore, the prevalence of respiratory disorders drives the growth of the capnography equipment market in North America.

Market Overview

The North America capnography equipment market is segmented into the US, Canada, and Mexico. The market growth in the region is attributed to the growing prevalence of respiratory diseases due to unhealthy lifestyles, rising technological advancements in capnography devices, and increasing government initiatives. According to CDC, cigarette smoking in the US contributes to 80-90% of lung cancer deaths. Also, CDC estimated that about 13 of every 100 adults (12.5%) in the US aged 18 years and above smoked cigarettes, which indicates that 16 million people of this age group suffer from smoking-related disease. Rising respiratory disorders propel the need for early detection. According to the American Cancer Society, second-hand smoke leads to about 7,000 lung cancer deaths in the US each year. Furthermore, about 25 million population in the US is suffering from asthma, according to The American College of Allergy, Asthma & Immunology. The American Heart Association (AHA) recommends the use of capnography monitoring to help physicians monitor the chest compressions quality to confirm endotracheal tube placement and use it as an early indicator of the return of spontaneous circulation. The Association for Radiologic and Imaging Nursing (ARIN) supports the use of capnography for patients with moderate sedation or analgesia during imaging environment procedures. Thus, increasing initiatives by guiding bodies promote the growth of the capnography equipment market in North America.

North America Capnography Equipment Market Segmentation

The North America capnography equipment market is segmented on the basis of product type, technology, application, end user, and country.

• Based on product type, the market is bifurcated into capnometers and capnography accessories & disposables. The capnography accessories & disposables segment held a larger market share in 2022.
• Based on technology, the North America capnography equipment market is segmented into mainstream capnography, sidestream capnography, and microstream capnography. The mainstream capnography segment held the largest market share in 2022.
• Based on application, the North America capnography equipment market is segmented into cardiac care, trauma and emergency care, procedural sedation, respiratory monitoring, and others. The cardiac care segment accounted for the largest market share in 2022.
• Based on end user, the North America capnography equipment market is segmented into hospitals, ambulatory surgery center, home care settings, and others. The hospitals segment held the largest market share in 2022.
• Based on country, the North America capnography equipment market is segmented into the US, Canada, and Mexico. The US held the largest market share in 2022. BD, Dragerwerk AG & Co. KGaA, General Electric Company, Hill Rom Holding Inc. (Baxter), ICU Medical Inc., Koninklijke Philips N.V., Masimo, Medtronic, Nihon Kohden Corporation, and SCHILLER Americas Inc. are among the leading companies operating in the capnography equipment market in North America.